Biotia is a US-based, fast-growing tech startup, born out of the Runway program at Cornell Tech and operating out of our CLIA lab in Brooklyn, New York. Our highly skilled lab, software, and business teams are like-minded in their approach. We have a passion for innovation and a culture centered around collaboration and curiosity. We are thought leaders in the infectious disease diagnostics space, leveraging a vast network in academia and industry to commercialize our revolutionary sequencing platform.

At Biotia, we fight infectious disease powered by AI software and genomics while developing the world’s leading microbial sequence database. We work with researchers, labs, and clinicians, leveraging high-complexity testing for rapid precision infectious disease discovery, providing critical insights to guide patient treatment and improve health outcomes.

Our work in infectious disease has included pioneering products for SARS-CoV-2 variant detection (received FDA EUA), launching of bioinformatic pipelines with NASA, characterization of hard-to-diagnose infections and bacterial outbreaks in hospitals, and development of new diagnostic tools for women’s health.